
Pharmacokinetics and pharmacodynamics of rivaroxaban and its effect on biomarkers of hypercoagulability in patients with chronic heart failure
Keywords: ترومبوز; anti-coagulants; drugs; cardiac output; pharmacokinetics; thrombosis;